César Hernández-Alcaraz1, Carlos A Aguilar-Salinas2, Kenny Mendoza-Herrera1, Andrea Pedroza-Tobías1,3, Salvador Villalpando1, Teresa Shamah-Levy4, Juan Rivera-Dommarco5, Mauricio Hernández-Ávila6, Simón Barquera1. 1. Centro de Investigación en Salud y Nutrición, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. 2. Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Mexico City, Mexico. 3. Institute for Global Health Sciences, University of California. San Francisco, United States. 4. Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. 5. Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. 6. Dirección de Prestaciones Económicas y Sociales, Instituto Mexicano del Seguro Social. Mexico City, Mexico.
Abstract
OBJECTIVE: To describe in a national sample 1) the prevalence, awareness, treatment and control of dyslipidemias 2) the prevalence of dyslipidemias through previous national surveys. MATERIALS AND METHODS: We analyzed data of the National Health and Nutrition Survey 2012, a representative cross-sectional study. Serum samples of 9 566 adults ≥20 years old with fasting ≥8 hours were analyzed for lipid fractions. Age-adjusted prevalences were calculated, by sociodemographic variables. Prevalence of awareness, treatment and control was estimated. A description of the dyslipidemia prevalence reported in previous surveys is reported. RESULTS: Hypoalphalipoproteinemia and elevated LDL-C are the most prevalent dyslipidemias in Mexican adults. One in four adults had hypercholesterolemia at the moment of the interview without previous diagnosis. Awareness, treatment and control of dyslipidemia were 12.6, 3.7 and 3.1%, respec- tively. CONCLUSIONS: Dyslipidemias are the most prevalent risk factor for cardiovascular diseases in Mexico. Public policies to increase awareness, access to therapy and sustained control are urgently needed.
OBJECTIVE: To describe in a national sample 1) the prevalence, awareness, treatment and control of dyslipidemias 2) the prevalence of dyslipidemias through previous national surveys. MATERIALS AND METHODS: We analyzed data of the National Health and Nutrition Survey 2012, a representative cross-sectional study. Serum samples of 9 566 adults ≥20 years old with fasting ≥8 hours were analyzed for lipid fractions. Age-adjusted prevalences were calculated, by sociodemographic variables. Prevalence of awareness, treatment and control was estimated. A description of the dyslipidemia prevalence reported in previous surveys is reported. RESULTS: Hypoalphalipoproteinemia and elevated LDL-C are the most prevalent dyslipidemias in Mexican adults. One in four adults had hypercholesterolemia at the moment of the interview without previous diagnosis. Awareness, treatment and control of dyslipidemia were 12.6, 3.7 and 3.1%, respec- tively. CONCLUSIONS: Dyslipidemias are the most prevalent risk factor for cardiovascular diseases in Mexico. Public policies to increase awareness, access to therapy and sustained control are urgently needed.
Entities:
Keywords:
Mexico; dyslipidemias; nutrition surveys; prevention and control
Authors: Pablo F Belaunzaran-Zamudio; Yanink Caro-Vega; Mark J Giganti; Jessica L Castilho; Brenda E Crabtree-Ramirez; Bryan E Shepherd; Fernando Mejía; Carina Cesar; Rodrigo C Moreira; Marcelo Wolff; Jean W Pape; Denis Padgett; Catherine C McGowan; Juan G Sierra-Madero Journal: PLoS One Date: 2020-06-17 Impact factor: 3.240
Authors: Estefanía Alcántara-Alonso; Fernando Molinar-Ramos; Jesús Alberto González-López; Viridiana Alcántara-Alonso; Marco Antonio Muñoz-Pérez; José Juan Lozano-Nuevo; Daniel Rabindranath Benítez-Maldonado; Elizabeth Mendoza-Portillo Journal: Clin Nutr ESPEN Date: 2021-05-07
Authors: Gilberto Vargas-Alarcón; María Del Carmen González-Salazar; Christian Vázquez-Vázquez; Adrián Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Juan Reyes-Barrera; Sergio A Criales-Vera; Marco Sánchez-Guerra; Citlalli Osorio-Yáñez; Rosalinda Posadas-Sánchez Journal: Front Genet Date: 2021-06-11 Impact factor: 4.599
Authors: Paola León-Mimila; Hugo Villamil-Ramírez; Luis R Macías-Kauffer; Leonor Jacobo-Albavera; Blanca E López-Contreras; Rosalinda Posadas-Sánchez; Carlos Posadas-Romero; Sandra Romero-Hidalgo; Sofía Morán-Ramos; Mayra Domínguez-Pérez; Marisol Olivares-Arevalo; Priscilla López-Montoya; Roberto Nieto-Guerra; Víctor Acuña-Alonzo; Gastón Macín-Pérez; Rodrigo Barquera-Lozano; Blanca E Del-Río-Navarro; Israel González-González; Francisco Campos-Pérez; Francisco Gómez-Pérez; Victor J Valdés; Alicia Sampieri; Juan G Reyes-García; Miriam Del C Carrasco-Portugal; Francisco J Flores-Murrieta; Carlos A Aguilar-Salinas; Gilberto Vargas-Alarcón; Diana Shih; Peter J Meikle; Anna C Calkin; Brian G Drew; Luis Vaca; Aldons J Lusis; Adriana Huertas-Vazquez; Teresa Villarreal-Molina; Samuel Canizales-Quinteros Journal: Arterioscler Thromb Vasc Biol Date: 2021-07-08 Impact factor: 10.514